For 2025, our focus remains: translating new data into clinical practice. The programme will consist of state-of-the-art lectures, case discussions and panel debates. Our faculty is a group of well-chosen international & multidisciplinary experts, who will discuss all hot topics of 2025 in renal cancer. There are no parallel sessions in order to maximise interaction.
We will take you on our journey to Lisbon and beyond. Prior to the meetings, we send out case challenges, where you can compare your opinion with peers & experts. These cases will be part of the RENALC-BLADDR-PROSCA programme during the meetings (3 December for RENALC). After the meetings, you will be fully updated on renal cancer management.
08:30-08:45 Official opening
Arnaldo Figueiredo, José Luís Passos Coelho
08:45-10:00 Advancements in imaging and local disease management
Moderator: Arnaldo Figueiredo, Lisa Pickering
Imaging innovations in RCC
Pieter De Visschere
Debate: Management of T1 tumours
Axel Bex, Riccardo Campi, Peter Hoskin, Géraldine Pignot
Emerging neoadjuvant treatment approaches
Axel Bex
Case presentation
Teele Kuusk
Panel discussion and Q&A
10:00-10:30 Update lecture: Metastatic pRCC: translating current evidence into clinical decision-making
Moderator: Sylvie Rottey
Presenter: Ignacio Durán
Panel case discussion: Ignacio Durán, Lisa Pickering, Thomas Powles (virtual)
10:30-11:00 Break
11:00-12:30 Case discussion session: From locally advanced to metastatic RCC
Moderators: Philippe Barthélémy, Bernadett Szabados
Panel: Philippe Barthélémy, Axel Bex, Raquel Brás, Riccardo Campi, Arnaldo Figueiredo, Mário Fontes-Sousa, Valérie Fonteyne, Teele Kuusk, Lisa Pickering, Géraldine Pignot, Sylvie Rottey, Bernadett Szabados
Mirrors of Medicine – case-based learning
Petros Grivas
Case presentation
Raquel Brás, Henning Plage
Management of high-risk RCC post-nephrectomy
Riccardo Campi
How to treat oligometastatic RCC?
Valérie Fonteyne
First-line treatment for metastatic RCC: IO/IO or IO/TKI?
Mário Fontes-Sousa
Progression after IO: What’s next?
Lisa Pickering
Panel discussion and Q&A
12:30-13:00 RENALC meets BLADDR session: When to stop IO?
Moderator: Ignacio Durán
Panel: Philippe Barthélémy, Raquel Brás, Sylvie Rottey, Bernadett Szabados
Case-based panel discussion
13:00 End of RENALC & lunch
Wednesday 3 December 2025
08:30-08:45 Official opening
Arnaldo Figueiredo, José Luís Passos Coelho
08:45-10:00 Advancements in imaging and local disease management
Moderator: Arnaldo Figueiredo, Lisa Pickering
Imaging innovations in RCC
Pieter De Visschere
Debate: Management of T1 tumours
Axel Bex, Riccardo Campi, Peter Hoskin, Géraldine Pignot
Emerging neoadjuvant treatment approaches
Axel Bex
Case presentation
Teele Kuusk
Panel discussion and Q&A
10:00-10:30 Update lecture: Metastatic pRCC: translating current evidence into clinical decision-making
Moderator: Sylvie Rottey
Presenter: Ignacio Durán
Panel case discussion: Ignacio Durán, Lisa Pickering, Thomas Powles (virtual)
10:30-11:00 Break
11:00-12:30 Case discussion session: From locally advanced to metastatic RCC
Moderators: Philippe Barthélémy, Bernadett Szabados
Panel: Philippe Barthélémy, Axel Bex, Raquel Brás, Riccardo Campi, Arnaldo Figueiredo, Mário Fontes-Sousa, Valérie Fonteyne, Teele Kuusk, Lisa Pickering, Géraldine Pignot, Sylvie Rottey, Bernadett Szabados
Mirrors of Medicine – case-based learning
Petros Grivas
Case presentation
Raquel Brás, Henning Plage
Management of high-risk RCC post-nephrectomy
Riccardo Campi
How to treat oligometastatic RCC?
Valérie Fonteyne
First-line treatment for metastatic RCC: IO/IO or IO/TKI?
Mário Fontes-Sousa
Progression after IO: What’s next?
Lisa Pickering
Panel discussion and Q&A
12:30-13:00 RENALC meets BLADDR session: When to stop IO?
Moderator: Ignacio Durán
Panel: Philippe Barthélémy, Raquel Brás, Sylvie Rottey, Bernadett Szabados
Case-based panel discussion